The R2 non-neuroinvasive HSV-1 vaccine affords protection from genital HSV-2 infections in a guinea pig model.

Bernstein, David I; Cardin, Rhonda D; Smith, Gregory A; Pickard, Gary E; Sollars, Patricia J; Dixon, David A; Pasula, Rajamouli; Bravo, Fernando J.

Afiliação

Bernstein DI; Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH, USA. david.bernstein@cchmc.org.
Cardin RD; School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA, USA.
Smith GA; Department of Microbiology-Immunology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Pickard GE; School of Veterinary Medicine and Biomedical Sciences, University of Nebraska, Lincoln, NE, USA.
Sollars PJ; School of Veterinary Medicine and Biomedical Sciences, University of Nebraska, Lincoln, NE, USA.
Dixon DA; Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH, USA.
Pasula R; Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH, USA.
Bravo FJ; Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH, USA.

NPJ Vaccines ; 5(1): 104, 2020 Nov 06.

Article em En | MEDLINE | ID: mdl-33298966

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article